TXMD · TherapeuticsMD, Inc. · Documents
$2.16
+0.06 (+2.86%)
At close · Sep 11
View the 10-Q filed Aug 11, 2026
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The potential impact of these factors in conjunction with the uncertainty of the capital markets raises substantial doubt about our ability to continue as a going concern for the next twelve months from the issuance of these financial statements.”View the 10-Q filed Aug 11, 2026
Customer concentration
— top 3 customers 100% of revenue
3 customers — 100% of revenue (the three and six months ended June 30, 2026)
“For the three and six months ended June 30, 2026, 100% of license revenue related to Mayne Pharma, Theramex and Knight.”
Market Cap
$25.00M
Shares
11.57M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-05-12 | 2026-05-02 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 10-K/A | 2026-04-01 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-01-21 | 2026-01-15 | |
| 8-K | 2025-12-16 | 2025-12-15 | |
| 8-K | 2025-11-13 | 2025-11-12 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| DEF 14A | 2025-11-03 | 2025-12-15 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 10-K/A | 2025-04-30 | 2024-12-31 | |
| 8-K | 2025-04-09 | 2025-04-08 | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2024-12-05 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| DEF 14A | 2024-10-25 | 2024-12-05 | |
| 8-K | 2024-09-20 | — | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-05-10 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 10-K/A | 2024-04-29 | 2023-12-31 | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2024-03-29 | — | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-08-18 | 2023-08-15 | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 8-K | 2023-08-14 | — | |
| 8-K | 2023-07-10 | 2023-07-07 | |
| 8-K | 2023-07-06 | 2023-06-29 | |
| 8-K | 2023-06-28 | 2023-06-26 | |
| DEF 14A | 2023-05-17 | 2023-06-26 | |
| 8-K | 2023-05-15 | — | |
| 10-Q | 2023-05-15 | 2023-03-31 | |
| 8-K | 2023-05-05 | 2023-05-01 | |
| 10-K/A | 2023-05-01 | 2022-12-31 | |
| 8-K | 2023-04-21 | — | |
| 10-K | 2023-04-07 | 2022-12-31 | |
| 8-K | 2023-04-07 | — | |
| 8-K | 2023-02-27 | 2023-02-21 | |
| 8-K | 2023-01-18 | 2023-01-11 |
Showing 1–50 of 131 filings